Need Assistance?
  • US & Canada:
    +1-844-BOC(262)-0123
  • UK: +44-20-3286-1088

Amythiamicin A

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Amythiamicin A is a cyclic thiazole peptide produced by Amycolatopsis sp. MI 481-42F4A. It has antibacterial activity against gram-positive bacteria.

Category
Functional Peptides
Catalog number
BAT-013253
CAS number
152741-89-4
Molecular Formula
C50H51N15O8S6
Molecular Weight
1182.43
IUPAC Name
(2S)-1-[(4S)-2-[2-[(18S,25S,35S)-21-methyl-18-[2-(methylamino)-2-oxoethyl]-16,23,30,33-tetraoxo-25,35-di(propan-2-yl)-3,13,20,27,37-pentathia-7,17,24,31,34,39,40,41,42,43-decazaheptacyclo[34.2.1.12,5.112,15.119,22.126,29.06,11]tritetraconta-1(38),2(43),4,6(11),7,9,12(42),14,19(41),21,26(40),28,36(39)-tridecaen-8-yl]-1,3-thiazol-4-yl]-4,5-dihydro-1,3-oxazole-4-carbonyl]pyrrolidine-2-carboxamide
Synonyms
MI 481-42F4A; Antibiotic MI 481-42F4A; NSC677423; Amythiamycin A
Appearance
Lyophilized Powder or Liquid
Purity
>98%
Density
1.7±0.1 g/cm3
Sequence
SCNCVCGVCCSCSP
Storage
Store at -20°C
Solubility
Soluble in Methanol, DMSO; Poorly soluble in Water, Hexane
InChI
InChI=1S/C50H51N15O8S6/c1-20(2)35-48-61-31(19-78-48)46-57-27(15-75-46)38-23(9-10-24(54-38)45-60-30(18-76-45)43-56-26(14-73-43)50(72)65-11-7-8-32(65)39(51)68)44-58-29(17-74-44)41(70)55-25(12-33(66)52-6)47-64-37(22(5)79-47)42(71)63-36(21(3)4)49-59-28(16-77-49)40(69)53-13-34(67)62-35/h9-10,15-21,25-26,32,35-36H,7-8,11-14H2,1-6H3,(H2,51,68)(H,52,66)(H,53,69)(H,55,70)(H,62,67)(H,63,71)/t25-,26-,32-,35-,36-/m0/s1
InChI Key
BAGBLRBLZUISAJ-DVMLEBHQSA-N
Canonical SMILES
CC1=C2C(=O)NC(C3=NC(=CS3)C(=O)NCC(=O)NC(C4=NC(=CS4)C5=NC(=CS5)C6=C(C=CC(=N6)C7=NC(=CS7)C8=NC(CO8)C(=O)N9CCCC9C(=O)N)C3=NC(=CS3)C(=O)NC(C(=N2)S1)CC(=O)NC)C(C)C)C(C)C
1. Total syntheses of amythiamicins A, B and C
K C Nicolaou, Dattatraya H Dethe, David Y-K Chen Chem Commun (Camb). 2008 Jun 21;(23):2632-4. doi: 10.1039/b805069b. Epub 2008 May 8.
Total syntheses of the thiopeptide antibiotics amythiamicins A, B and C are reported.
2. Novel antibiotics, amythiamicins. III. Structure elucidations of amythiamicins A, B and C
K Shimanaka, Y Takahashi, H Iinuma, H Naganawa, T Takeuchi J Antibiot (Tokyo). 1994 Oct;47(10):1153-9. doi: 10.7164/antibiotics.47.1153.
The structures of novel antimicrobial antibiotics, amythiamicins A, B and C, were elucidated by chemical degradations and NMR spectral analyses. The main frame from C-1 to C-41 of these antibiotics was the same as that of amythiamicin D. Amino acid autoanalyses of amythiamicins A, B and C showed that these have another one mole of serine and proline in comparison with amythiamicin D. Stereochemistries of both amino acids were determined to be L by chiral HPLC. These seryl-prolyl residues in amythiamicins A, B and C are attached at C-41 through an oxazoline ring, amide and ester bond, respectively.
3. Antibiotic inhibitors of organellar protein synthesis in Plasmodium falciparum
B Clough, K Rangachari, M Strath, P R Preiser, R J Wilson Protist. 1999 Aug;150(2):189-95. doi: 10.1016/s1434-4610(99)70021-0.
Elongation factor Tu (EF-Tu) is encoded by the tuf gene of the plastid organelle of the malaria parasite Plasmodium falciparum. A range of structurally unrelated inhibitors of this GTP-dependent translation factor was shown to have antimalarial activity in blood cultures. The most active was the cyclic thiazolyl peptide amythiamicin A with an IC50 = 0.01 microM. Demonstrable complexes were formed in vitro between a recombinant version of P. falciparum EF-Tu(pl) and inhibitors that bind to different sites on EF-Tu; these included the antibiotics kirromycin, GE2270A and enacyloxin IIa.
Online Inquiry
0
Inquiry Basket

No data available, please add!

Delete selectedGo to checkout

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

x